Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CLSK | CURB |
|---|---|---|
| Price | $12.48 | $27.86 |
| Change today | ▼ 2.04% | ▼ 1.45% |
| Market cap | $3.21B | $3.20B |
| Return, 3 months | 0.0% | -8.6% |
| Return, year to date | +23.3% | +22.2% |
| Return, 1 year | -28.4% | +23.2% |
| P/E (TTM) | -3.3 | 103.2 |
| P/B | 4.2 | 1.5 |
| P/E percentile vs own 5y | 60th | – |
| Dividend yield | – | 2.37% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +91.1% | +27.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 44 | 37 |
| 30-day volatility | 75.3% | 14.9% |
| Max drawdown, 1 year | -64.7% | -11.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
